Antibody Characterization Program
NCI's Antibody Characterization Program comprehensively characterizes monoclonal antibodies or other renewable affinity reagents for use in cancer-related research. It operates via its Antibody Characterization Laboratory, which is located at the Frederick National Laboratory for Cancer Research.
Clinical Pharmacodynamic Biomarker Assays
The Division of Cancer Treatment and Diagnosis (DCTD) Clinical Pharmacodynamic Program has developed pharmacodynamic biomarker assays that are intended to be used to investigate drug and downstream drug-induced effects.